Mesoblast Ltd
MSB•Health Care•Biotechnology•Last updated: Dec 25
About
Mesoblast Ltd is a global leader in allogeneic cellular medicines for inflammatory diseases. The company develops and commercializes innovative cellular medicines based on its proprietary mesenchymal lineage cell technology platform. Mesoblast's main segments include cardiovascular, inflammatory, and orthopedic diseases, with products such as remestemcel-L for acute respiratory distress syndrome and chronic heart failure.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- MSB
Related Shares
Investor Resources
Should you buy Mesoblast Ltd right now?
While MSB looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now